Erysipelothrix rhusiopathiae bacteremia treated with linezolid.

Alex Berman, Samuel C O Opara, Yun F Wang, Michael H Woodworth, Danielle Barrios Steed
Author Information
  1. Alex Berman: Division of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  2. Samuel C O Opara: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  3. Yun F Wang: Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  4. Michael H Woodworth: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  5. Danielle Barrios Steed: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: danielle.barrios.steed@emory.edu.

Abstract

Erysipelothrix rhusiopathiae is a common zoonotic pathogen that rarely causes diseases in humans. It has three main disease manifestations: a localized cutaneous, a disseminated cutaneous, and a systemic form of infection, typically characterized as bacteremia with or without endocarditis. Human infections are often associated with occupational exposure to animals, animal products, or their excreta. We present a case of a 60-year-old woman found to have E. rhusiopathiae bacteremia associated with a leg laceration sustained after she fell into a sewer drain. Germane animal exposures were not identified; thus, the source of bacterium was attributed to sewage or sewage-contaminated water. She was initially treated with intravenous penicillin with clinical improvement. However, given the patient's social factors, prolonged oral antimicrobial therapy was considered. E. rhusiopathiae is routinely susceptible to penicillin, cephalosporins, and fluoroquinolones but resistant to vancomycin. The data on alternatives to beta-lactam therapy are limited. We report a case of E. rhusiopathiae bacteremia successfully treated with oral linezolid.

Keywords

References

  1. Rev Infect Dis. 1988 Mar-Apr;10(2):317-25 [PMID: 3287562]
  2. Diagn Microbiol Infect Dis. 2013 Nov;77(3):280-1 [PMID: 23988830]
  3. J Clin Pathol. 2008 Nov;61(11):1223-4 [PMID: 18818268]
  4. Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1269-76 [PMID: 27180242]
  5. Clin Infect Dis. 2019 Jul 18;69(3):381-387 [PMID: 30351401]
  6. N Engl J Med. 2019 Jan 31;380(5):415-424 [PMID: 30152252]
  7. Int J Antimicrob Agents. 2023 May;61(5):106763 [PMID: 36804370]
  8. Antimicrob Agents Chemother. 1990 Oct;34(10):2038-40 [PMID: 2291674]
  9. Germs. 2022 Mar 31;12(1):16-31 [PMID: 35601944]
  10. Methods Mol Biol. 2004;268:199-205 [PMID: 15156031]
  11. Clin Microbiol Rev. 1989 Oct;2(4):354-9 [PMID: 2680056]

Grants

  1. K23 AI144036/NIAID NIH HHS

MeSH Term

Humans
Linezolid
Female
Bacteremia
Middle Aged
Erysipelothrix
Erysipelothrix Infections
Anti-Bacterial Agents

Chemicals

Linezolid
Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0rhusiopathiaebacteremiaErysipelothrixEtreatedcutaneousassociatedanimalcasepenicillinoraltherapylinezolidcommonzoonoticpathogenrarelycausesdiseaseshumansthreemaindiseasemanifestations:localizeddisseminatedsystemicforminfectiontypicallycharacterizedwithoutendocarditisHumaninfectionsoftenoccupationalexposureanimalsproductsexcretapresent60-year-oldwomanfoundleglacerationsustainedfellsewerdrainGermaneexposuresidentifiedthussourcebacteriumattributedsewagesewage-contaminatedwaterinitiallyintravenousclinicalimprovementHowevergivenpatient'ssocialfactorsprolongedantimicrobialconsideredroutinelysusceptiblecephalosporinsfluoroquinolonesresistantvancomycindataalternativesbeta-lactamlimitedreportsuccessfullyGram-positiveLinezolidZoonoticpathogens

Similar Articles

Cited By

No available data.